NYSE$ITGR

Integer Holdings Corporation · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Integer Holdings Corporation reported strong Q4 sequential sales and profit increase.

Integer Holdings Corporation reported Q4 2020 results with sales at the high end of guidance and profit above guidance. Strong cash management led to a $123 million reduction in net total debt in 2020.

  • Q4 results reflect the beginning of the recovery from the pandemic.
  • Sales and profit improved significantly from the third quarter.
  • Integer's associates continued to deliver for customers and their patients.
  • Integer increased investments in strategy versus 2019.

Headline financials

Total Revenue

$269M

Previous: $326M-17.4%
EPS (adj)

$0.71

Previous: $1.25-43.2%
Capital Expenditures

$11.7M

Previous: $23.5M-50.4%
Free Cash Flow

$59.5M

Previous: $29.9M+98.9%
Net Income

$15.4M

Previous: $6.44M+139.4%
Operating Income

$27.6M

Previous: $15.6M+77.4%
Gross Profit

$73.2M

Previous: $95.9M-23.7%
Cash & Equivalents

$49.2M

Previous: $13.5M+263.5%
Total Assets

$2.37B

Previous: $2.35B+0.8%
Stock-Based Comp

$2.93M

Previous: $2.4M+22.3%

Revenue & EPS history

Integer · Revenue · Quarterly

$269M

Q4 2020-17.4%vs Q4 2019
Beat estimate in 16 of 16 quarters(100%)
ActualEstimate

Revenue by segment

Integer · $266M total across 2 segments · Q1 2023

  • Cardio & Vascular
    $149M
  • Cardiac Rhythm Management & Neuromodulation
    $117M

Forward guidance

Full year 2021 financial outlook reflects an expected recovery of the industry with year-over-year sales growth projected to be 8% to 12%.

Tailwinds

  • Integer’s first quarter sales are projected to be sequentially better than the fourth quarter of 2020
  • Second quarter should be similar or slightly better than the first quarter.
  • Operating income to reflect the increase in sales
  • Operating income to reflect the continued execution of manufacturing excellence strategic imperative.
  • Project to generate $90 to $110 of free cash flow

Headwinds

  • Improvement in the second half of 2021 to be determined by the pace of COVID-19 recovery.
  • Adjusted EBITDA is expected to consist of Adjusted net income, excluding items such as depreciation, interest, stock-based compensation and taxes totaling approximately $116 million to $120 million.
  • Dependence upon a limited number of customers
  • Pricing pressures that we face from customers
  • The intense competition we face and our ability to successfully market our products

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

-0.5%

Avg return

Earnings day

+0.4%

Avg return

5 days after

+2.4%

Avg return

30 days after

41%

25 / 61 earnings

Positive

+16.4%

Q3 2016

Best reaction

-33.2%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.3%+2.6%+6.8%
Q4 2025-3.4%+0.7%-2.8%
Q3 2025-33.2%-37.7%-35.8%
Q1 2025+0.8%+5.3%-1.8%
Q4 2024-5.6%-10.8%-19.6%
Q3 2024-0.6%+2.8%+9.2%
Q2 2024-6.2%-2.5%+1.7%
Q1 2024-11.1%-9.4%-0.5%
Q4 2023-5.4%-4.5%+8.3%
Q3 2023+13.6%+16.9%+29.0%
Q2 2023+5.5%+6.5%-5.4%
Q1 2023+1.3%+0.3%-1.2%
Q4 2022+6.0%+2.4%+1.4%
Q3 2022+4.2%+6.4%+20.0%
Q2 2022-0.5%-0.3%-5.2%
Q1 2022-5.1%-1.6%+1.7%
Q4 2021-2.2%-5.5%-7.2%
Q3 2021-1.6%-2.1%-9.0%
Q2 2021-0.9%-3.2%-0.5%
Q1 2021-2.1%-2.6%-5.7%
Q4 2020+9.6%+9.3%+15.5%
Q3 2020-4.1%-4.6%+19.3%
Q2 2020-6.0%-9.3%-0.1%
Q1 2020+6.3%+2.3%+19.0%
Q4 2019+4.9%+1.0%-45.2%
Q3 2019-1.1%-1.1%-2.3%
Q2 2019-3.7%-7.8%-17.3%
Q1 2019+10.7%+11.7%+3.5%
Q4 2018+0.7%+3.0%-1.3%
Q3 2018+13.1%+18.0%+18.9%
Q2 2018-0.9%+0.5%+11.9%
Q1 2018+13.0%+16.8%+17.6%
Q4 2017+16.0%+13.9%+24.6%
Q3 2017-2.7%-4.1%-2.2%
Q2 2017+2.7%+2.0%+0.4%
Q1 2017+2.5%+12.3%+13.9%
Q4 2016-0.7%+2.9%+7.0%
Q3 2016+16.4%+15.8%+51.9%
Q2 2016-30.4%-29.7%-26.5%
Q1 2016-10.4%
Q4 2015-14.3%
Q3 2015+6.4%
Q2 2015+4.0%
Q1 2015-3.5%
Q4 2014+1.0%
Q1 2014-4.0%
Q3 2014+6.8%
Q2 2014+2.9%
Q1 2013-5.1%
Q4 2012+0.1%
Q3 2012-0.5%
Q2 2012+1.3%
Q1 2011-1.4%
Q1 2012+0.6%
Q4 2011-2.8%
Q1 2010-2.8%
Q3 2010-3.6%
Q3 2011-3.6%
Q2 2011-0.8%
Q2 2010-0.8%
Q4 2010-0.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro